Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
about
Progesterone inhibition of neuronal calcium signaling underlies aspects of progesterone-mediated neuroprotectionCombination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and diseaseProgesterone receptors: form and function in brainA high soy diet enhances neurotropin receptor and Bcl-XL gene expression in the brains of ovariectomized female ratsEstrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.Female reproductive factors, menopausal hormone use, and Parkinson's disease.ESTROGEN REPLACEMENT THERAPY FOR STROKE.Allopregnanolone and its precursor progesterone do not reduce injury after experimental stroke in hypertensive rats - role of postoperative temperature regulation?Formulations of hormone therapy and risk of Parkinson's disease.Oestrogen receptors enhance dopamine neurone survival in rat midbrain.Antioxidants as treatment for neurodegenerative disorders.Manganese-induced NF-kappaB activation and nitrosative stress is decreased by estrogen in juvenile miceDifferential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells.Selective estrogen receptor modulators regulate dendritic spine plasticity in the hippocampus of male ratsThe oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.Selective estrogen receptor modulators (SERMs) enhance neurogenesis and spine density following focal cerebral ischemiaPlasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP MiceNeuroprotective actions of neurosteroidsMale/Female differences in neuroprotection and neuromodulation of brain dopamineChanges in the content of estrogen alpha and progesterone receptors during differentiation of mouse embryonic stem cells to dopamine neurons.Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell-derived dopaminergic neurons.Implications for estrogens in Parkinson's disease: an epidemiological approach.Soy phytoestrogens are neuroprotective against stroke-like injury in vitro.Progesterone increases brain-derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants.Neuroprotective actions of brain aromatase.Reproductive factors, exogenous estrogen use, and risk of Parkinson's diseaseProgesterone increases dopamine neurone number in differentiating mouse embryonic stem cells.Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway.Neuroprotective actions of selective estrogen receptor modulators.Complexities of oestrogen in stroke.Sexual dimorphism in schizophrenia: is there a need for gender-based protocols?Oestrogen receptors and signalling pathways: implications for neuroprotective effects of sex steroids in Parkinson's disease.Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicityProgesterone and 17β-estradiol increase differentiation of mouse embryonic stem cells to motor neurons.Trichostatin A enhances glutamate transporter GLT-1 mRNA levels in C6 glioma cells via neurosteroid-mediated cell differentiation.17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death.Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice.Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells.Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.
P2860
Q24616548-66A1A17C-39B9-4ED1-B2DE-3F7D39ECA60BQ24633922-CB671CB6-142C-458E-BEC6-C2EC485ECF6DQ28274391-2CA0A977-4B33-4328-B31B-BA518887AD6EQ28574199-40A2A519-18D8-4A19-8A7F-9005C8DF9EAAQ30478476-EC03746B-FB1E-469B-9261-26F895D90D71Q33756791-A041749C-A4F6-426D-AFB9-726476664DB9Q33840436-DE280924-46D6-44BB-A230-893ACFC2EE8BQ34232460-41A130D6-9FE1-4C77-8A76-9B5885BAEB8BQ34437648-F8A55828-F1FD-46ED-B19F-C5EA89A3C61CQ34483979-37EAB870-C6D4-421B-AB26-71099D4ACB30Q34974866-A3EE1943-3BA7-464F-8B68-E3C3860F6DF1Q35127704-5BFE4ADA-0E10-4718-BFDD-0B73AE55452FQ35492403-9E7AD263-70CA-446B-9B16-E2BCE0300A1FQ35550876-1C33E439-CA73-48CA-BEBA-88C2AA9847FBQ35552497-7F8E363E-A482-4AE1-A372-80C3DB7FEDF6Q35569533-BEB80C57-214C-43B1-BF1F-F55F863950F2Q35951218-A5F2C430-D907-46E0-BD0F-B18F5348F753Q35971511-9158B79E-5EE1-42A4-BD64-7793A8EBA08DQ35972056-42BF301B-3B21-483B-919F-B614DE4DD990Q36094337-EDF7379B-AA9A-4AAA-93EA-E29C90493347Q36102771-09CC364E-933C-43F0-A9DB-DE236F6D7141Q36613561-C1AD28B9-DA54-4C9C-A55E-8D9393866DA4Q36721786-71B0C6D6-9F21-4989-8388-3AA617A5D230Q37121148-04593DF7-BA34-4CE7-B890-40C4633A5647Q37218939-F2EA81E9-F319-465C-99B1-CEB9D524D091Q37238625-1E901F76-68C7-4DF8-9DC9-1A07E173815CQ37362137-25281952-46D6-4380-AE85-2A8C012D1340Q37390372-5702449F-F74B-40A0-A192-CD9661EF7DDCQ37395900-06380F01-C794-4D47-81B1-833001690B2DQ37479919-3E25F267-B1B9-46CC-8D72-3D7387D4DEF0Q37650744-0342EBB7-83CB-4F90-9487-D257661EF229Q37896624-A846152A-AB52-4DB9-BDF5-2767A0729FFAQ37905899-54959255-CED2-4CF1-89B5-0AA56F601D9EQ38234167-49CF50BE-6363-4119-B311-762DA1FEAC6CQ38332083-70393412-FA98-4ACA-8758-1FAD1E34213FQ39328748-5FDB8CCC-2FBB-4B4D-B677-7ABBDB9978D1Q40566485-2588D6A5-20A1-4BC7-AD85-1C862078D4EEQ44126277-7DD8A287-48C7-45A8-9F23-0D659254D393Q44141743-0B5293CF-0718-464D-BB31-CF255BD29A1AQ44981188-4320E9E2-9627-4233-9C7B-D92D9D32E3E2
P2860
Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Neuroprotective properties of ...... loxifene in MPTP C57Bl/6 mice.
@en
Neuroprotective properties of ...... loxifene in MPTP C57Bl/6 mice.
@nl
type
label
Neuroprotective properties of ...... loxifene in MPTP C57Bl/6 mice.
@en
Neuroprotective properties of ...... loxifene in MPTP C57Bl/6 mice.
@nl
prefLabel
Neuroprotective properties of ...... loxifene in MPTP C57Bl/6 mice.
@en
Neuroprotective properties of ...... loxifene in MPTP C57Bl/6 mice.
@nl
P2093
P2860
P356
P1433
P1476
Neuroprotective properties of ...... loxifene in MPTP C57Bl/6 mice.
@en
P2093
Di Paolo T
Grandbois M
Morissette M
Pélaprat D
P2860
P304
P356
10.1002/SYN.1067
P577
2001-08-01T00:00:00Z